FDA Clears Oral Film Formulation of ALS Drug Riluzole (Exservan) FDA Clears Oral Film Formulation of ALS Drug Riluzole (Exservan)

An oral film formulation of riluzole may help overcome challenges of disease-related dysphagia in patients with amyotrophic lateral sclerosis.FDA Approvals

Source: Medscape Neurology and Neurosurgery Headlines - November 26, 2019 Category: Neurology Tags: Neurology & Neurosurgery News Alert Source Type: news